Eagle Asset Management Inc. lifted its position in Merit Medical Systems, Inc. (NASDAQ:MMSI) by 2.0% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 605,511 shares of the medical instruments supplier’s stock after acquiring an additional 11,779 shares during the period. Eagle Asset Management Inc. owned 1.21% of Merit Medical Systems worth $26,703,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently made changes to their positions in the company. LS Investment Advisors LLC lifted its stake in Merit Medical Systems by 8.1% in the 2nd quarter. LS Investment Advisors LLC now owns 3,694 shares of the medical instruments supplier’s stock valued at $141,000 after buying an additional 277 shares in the last quarter. Advisors Asset Management Inc. lifted its position in Merit Medical Systems by 28.2% during the 2nd quarter. Advisors Asset Management Inc. now owns 3,723 shares of the medical instruments supplier’s stock worth $142,000 after buying an additional 820 shares in the last quarter. Ameritas Investment Partners Inc. boosted its stake in shares of Merit Medical Systems by 20.9% in the 2nd quarter. Ameritas Investment Partners Inc. now owns 4,272 shares of the medical instruments supplier’s stock valued at $163,000 after purchasing an additional 738 shares in the last quarter. SG Americas Securities LLC bought a new position in Merit Medical Systems during the 3rd quarter worth $189,000. Finally, Riverhead Capital Management LLC grew its position in Merit Medical Systems by 67.7% in the second quarter. Riverhead Capital Management LLC now owns 5,198 shares of the medical instruments supplier’s stock valued at $198,000 after acquiring an additional 2,098 shares during the last quarter. 90.91% of the stock is currently owned by institutional investors.

In related news, Director Kent W. Stanger sold 670 shares of the company’s stock in a transaction on Thursday, September 14th. The shares were sold at an average price of $42.06, for a total transaction of $28,180.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 5.00% of the stock is owned by insiders.

A number of research firms have weighed in on MMSI. Canaccord Genuity restated a “buy” rating and set a $45.00 target price on shares of Merit Medical Systems in a report on Wednesday, September 6th. ValuEngine raised shares of Merit Medical Systems from a “hold” rating to a “buy” rating in a report on Tuesday, November 21st. SunTrust Banks set a $47.00 price target on shares of Merit Medical Systems and gave the stock a “buy” rating in a research report on Thursday, November 16th. Zacks Investment Research upgraded Merit Medical Systems from a “hold” rating to a “buy” rating and set a $43.00 target price on the stock in a research report on Saturday, October 28th. Finally, Wells Fargo & Company restated an “outperform” rating and set a $51.00 target price (up previously from $46.00) on shares of Merit Medical Systems in a report on Thursday. One analyst has rated the stock with a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average price target of $43.77.

Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) opened at $43.45 on Friday. Merit Medical Systems, Inc. has a 12-month low of $23.25 and a 12-month high of $45.50. The company has a market capitalization of $2,211.26, a price-to-earnings ratio of 34.69, a P/E/G ratio of 2.98 and a beta of 1.20. The company has a debt-to-equity ratio of 0.39, a current ratio of 2.78 and a quick ratio of 1.43.

Merit Medical Systems (NASDAQ:MMSI) last issued its earnings results on Wednesday, October 25th. The medical instruments supplier reported $0.32 EPS for the quarter, topping the consensus estimate of $0.30 by $0.02. The business had revenue of $179.30 million during the quarter, compared to the consensus estimate of $181.28 million. Merit Medical Systems had a return on equity of 9.86% and a net margin of 4.06%. The firm’s revenue was up 14.2% compared to the same quarter last year. During the same quarter last year, the company earned $0.26 EPS. equities analysts anticipate that Merit Medical Systems, Inc. will post 1.27 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “Eagle Asset Management Inc. Acquires 11,779 Shares of Merit Medical Systems, Inc. (MMSI)” was originally reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this story on another site, it was stolen and republished in violation of international copyright and trademark law. The legal version of this story can be viewed at https://www.thecerbatgem.com/2017/12/01/eagle-asset-management-inc-acquires-11779-shares-of-merit-medical-systems-inc-mmsi.html.

About Merit Medical Systems

Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.

Institutional Ownership by Quarter for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Stock Ratings for Merit Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems Inc. and related stocks with our FREE daily email newsletter.